You are here

• Home
• Therapy Areas
• Neuroscience

• A Phase I, Single Center, Randomized, Double-Blind, Placebo-Controlled Single Ascending Oral Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7268 in Healthy Japanese Subjects

Disease

anxiety, depression

Drug Name

AZD7268

Generic Name

AZD7268

Sponsor

AstraZeneca

Drug Status

Discontinued

Phase

I

Start Date

May 29, 2009

Study Name

D1151C00002

Study Id

D1151C00002

ClinicalTrials.gov ID

NCT00912353

Recruiting Status

Closed

Protocol Status

Not Available

Report

Feb 26, 2010

• D1151C00002.pdf (611 KB)

Page tools

• Print
• Bookmark this page